Background and Aims: Sphingosine 1-phosphate (S1P) accounts for antiatherogenic properties of high-density lipoproteins, but the S1P receptor subtype mediating the atheroprotective effects of S1P and the underlying molecular mechanisms remain enigmatic. Experimental models engineered to amplify the signaling of endogenous S1P over its specific receptors may help in clarifying this issue. To this purpose, we generated a mouse model overexpressing S1P receptor type 1 (S1P1) specifically in the myeloid compartment and studied the effect on atherosclerosis development.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
030 / #1045 Track 2 - Metabolism of Lipids and Lipoproteins STEROLS AT THE CROSSROAD OF METABOLIC PATHWAYS 10-06-2020 10:00 AM - 11:13 AM
© 2020 Published by Elsevier Inc.